Serotonin Reuptake Inhibition Reduces NMDAR-Associated Reward Liability Without Compromising Rapid Antidepressant Efficacy
L. Pan, G. Wang, J. Ji, Y. Cai, Y. Pang, Y. Chen, Q. Lu, X. Tang, Z. Hu, B. Zheng, Y. Xiang, Q. Hou, K. Nie, j. zhao, T. Hu, , Jingshan Shen
This study shows that combining serotonin reuptake inhibition with NMDAR antagonism reduces reward-related effects while maintaining rapid antidepressant efficacy.
bioRxiv · Nov 9, 2026 · PreprintNeuroscience